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Abstract
Accurate HPV typing is essential for evaluation and monitoring of HPV vaccines, for second-line testing in cervical cancer screening, and in
epidemiological surveys. In this study, we set up and assessed in clinical samples a new HPV typing method based on 454 next-generation
sequencing (NGS) of HPV L1 amplicons, generated by using a modiﬁed PGMY primer set with improved sensitivity for some HPV types that
are not targeted by standard PGMY primers. By using a median 12 800-fold coverage, the NGS method allowed us to correctly identify all
high-risk HPV types, in either single or multiple infections, with a sensitivity of 50 genome equivalents, as demonstrated by testing WHO
LabNet EQA sample panels. Analysis of mixtures of HPV16- and HPV18-positive cell lines demonstrated that the NGS method could
reproducibly quantify the proportion of each HPV type in multiple infections in a wide dynamic range. Testing of HPV-positive clinical
samples showed that NGS could correctly identify a high number of HPV types in multiple infections. The NGS method was also effective in
the analysis of a set of cervical specimens with discordant results at hybrid capture 2 and line probe assays. In conclusion, a new HPV typing
method based on 454 pyrosequencing was set up. This method was sensitive, speciﬁc, quantitative and precise in both single and multiple
infections. It could identify a wide range of HPV types and might potentially discover new HPV types.
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Abstract
Recent developments in molecular diagnostic tools have led to the easy and rapid detection of a large number of rhinovirus (HRV) strains.
However, the lack of clinical and epidemiological data hampers the interpretation of these diagnostic ﬁndings. From October 2009 to
January 2011, we conducted a prospective study in hospitalized children from whom samples were taken for the detection of respiratory
viruses. Clinical, epidemiological and microbiological data from 644 patients with 904 disease episodes were collected. When HRV tested
positive, strains were further characterized by sequencing the VP4/VP2 region of the HRV genome. HRV was the single respiratory virus
detected in 254 disease episodes (28%). Overall, 99 different serotypes were detected (47% HRV-A, 12% HRV-B, 39% HRV-C). Patients
with HRV had more underlying pulmonary illness compared with patients with no virus (p 0.01), or patients with another respiratory virus
besides HRV (p 0.007). Furthermore, cough, shortness of breath and a need for oxygen were signiﬁcantly more present in patients with
HRV infection. Particularly, patients with HRV-B required extra oxygen. No respiratory symptom, except for oxygen need, was predictive
of the presence of HRV. In 22% of HRV-positive disease episodes, HRV infection was hospital acquired. Phylogenetic analysis revealed
several clusters of HRV; in more than 25% of these clusters epidemiological information was suggestive of transmission within speciﬁc
wards. In conclusion, the detection of HRV may help in explaining respiratory illness, particular in patients with pulmonary co-morbidities.
Identifying HRV provides opportunities for timely implementation of infection control measures to prevent intra-hospital transmission.
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